HIGHLIGHTS
- who: Wiebe M. C. Top et al. from the Department of Internal Medicine, Treant Care Group, AA Hoogeveen, The Netherlands Department of Internal Medicine, University Medical Center Groningen have published the paper: Metformin: A Narrative Review of Its Potential Benefits for Cardiovascular Disease, Cancer and Dementia, in the Journal: Pharmaceuticals 2022, 15, x FOR PEER REVIEW of /2022/
- what: There have been several additional analyses of the HOME trial focusing on cardiovascular aspects. A strength of this study is that the effects of SU treatment and metformin can be assessed separately. This analysis shows a . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.